Related Experiment Videos
[Drug side effects on the bronchi and lung]
J C Gartmann1, M Kuhn, K Hartmann
1Schweizerische Arzneimittel-Nebenwirkungs-Zentrale SANZ.
Therapeutische Umschau. Revue Therapeutique
|January 1, 1993
Summary
Adverse drug reactions affecting the respiratory system are a notable concern, with common culprits including ACE inhibitors and NSAIDs. Careful case analysis and literature review are crucial for diagnosing these drug-induced respiratory conditions.
Area of Science:
- Pharmacovigilance and Respiratory Medicine
- Adverse Drug Reactions (ADRs) and Pulmonary Complications
Context:
- Analysis of 4415 reports to the Spontaneous Adverse Drug Reactions Center, SANZ, between 1981 and 1990.
- Respiratory diseases constitute approximately 4% of reported adverse drug reactions.
Purpose:
- To identify common respiratory adverse drug reactions and discuss diagnostic methodologies.
- To highlight the signal-generating function of spontaneous reporting systems for ADRs.
Summary:
- Common ADRs include cough (ACE inhibitors), asthma exacerbations (NSAIDs, beta-blockers), interstitial pneumopathy (amiodarone, sulfonamides), and respiratory depression (benzodiazepines).
- Spontaneous reporting systems are valuable for detecting potential safety signals but do not establish incidence rates.
- Diagnostic procedures emphasize detailed case analysis, temporal correlation, and literature review.
Impact:
- Underscores the importance of considering drug-induced respiratory conditions in clinical practice.
- Provides a framework for evaluating suspected adverse drug reactions using established diagnostic principles.
- Informs healthcare professionals about potential pulmonary risks associated with specific drug classes.